Literature DB >> 9812599

[Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].

X Huang1, Y Lian, Q Wang.   

Abstract

Common marmosets with negative serum antibodies against hepatitis A virus (anti-HAV) and normal liver functions were used for the tests of passage of H2 vaccine strain of HAV to explore its residual virulence after attenuation and possibility of its reversion. Common marmosets were inoculated with attenuated live vaccine, and fecal suspension and/or proliferative liquid in tissue culture of the progeny of vaccine HAV excreted from their feces were passaged in common marmosets. Result of three serial passages in vivo indicated that there was no significant difference in serum anti-HAV titer, and no or low-level changes in activities of liver enzymes, no pathological changes in liver tissues observed, and detectable but minimal HAV was shed in stool of the all animals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9812599

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  2 in total

1.  The infectivity and pathogenicity of hepatitis A virus live-attenuated vaccine strain H2 in type I interferon receptor-deficient mice.

Authors:  Qing-Qing Ma; Hong-Jiang Wang; Jian Li; Meng-Qi Li; Tian-Shu Cao; Xiao-Yan Wu; Hong-Ying Qiu; Hui Zhao; Cheng-Feng Qin
Journal:  Virol Sin       Date:  2022-07-19       Impact factor: 6.947

Review 2.  Live attenuated hepatitis A vaccines developed in China.

Authors:  Zhi-Yi Xu; Xuan-Yi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.